All stocks ยท MEDICAMEQ
MB

Medicamen Biotech Ltd.

MEDICAMEQ BSE Drug Manufacturers - Specialty & Generic Healthcare

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms,โ€ฆ

ISIN INE646B01010
Listed โ€”
Quarters tracked 13
Filings 19 docs

About

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.

Key Metrics

as of Sep 2026
Market Cap365 Cr
P/E33.70
Div Yield0.37 %
Book Valueโ‚น203.00
52w Highโ‚น454.00
52w Lowโ‚น210.00
Face Valueโ‚น10.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 47.90 60.65 46.91 47.17 43.04 29.61 45.14 44.74 43.05 47.32 46.50 43.54 41.94
Expenses 43.57 55.22 42.53 42.01 38.43 31.22 38.43 39.43 39.60 41.57 41.60 38.89 34.99
Operating Profit 4.33 5.43 4.38 5.16 4.61 -1.61 6.71 5.31 3.45 5.75 4.90 4.65 6.95
OPM % 9.04 8.95 9.34 10.94 10.71 -5.44 14.86 11.87 8.01 12.15 10.54 10.68 16.57
Other Income 0.86 1.74 0.53 0.37 0.47 5.23 0.14 0.29 0.59 0.57 0.83 0.55 0.38
Depreciation 1.79 1.73 1.83 1.86 1.80 0.48 2.21 2.61 1.77 1.77 1.80 1.82 1.69
Interest 0.83 0.38 0.97 0.99 1.15 0.65 0.76 1.04 0.71 1.89 0.65 0.91 0.96
Profit before tax 2.57 5.06 2.11 2.68 2.13 2.49 3.88 1.95 1.56 2.66 3.28 2.47 4.68
Tax % 28.40 12.06 22.27 21.27 24.88 25.30 24.74 53.85 48.72 22.93 38.11 39.68 15.81
Net Profit 1.85 4.45 1.64 2.12 1.60 1.87 2.92 0.91 0.80 2.04 2.03 1.47 3.95
EPS in Rs 1.56 2.85 1.61 1.97 1.59 1.90 2.73 1.15 1.06 1.68 1.90 1.19 3.30

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Sales 198.00163.00179.00141.00115.00113.00125.00123.00
Expenses 178.00148.00156.00117.0091.0093.00106.00105.00
Operating Profit 20.0014.0024.0024.0024.0020.0020.0017.00
OPM % 10.009.0013.0017.0021.0017.0016.0014.00
Other Income 3.006.002.002.002.001.002.004.00
Interest 4.004.006.003.002.002.001.001.00
Depreciation 7.007.007.006.006.003.002.002.00
Profit before tax 12.0010.0013.0017.0018.0016.0018.0018.00
Tax % 18.0034.0027.0014.0018.0026.0026.0031.00
Net Profit 10.007.009.0015.0015.0012.0013.0012.00
EPS in Rs 7.115.598.6011.7312.209.9310.8810.28
Dividend Payout % 14.0018.0012.009.008.0010.005.0010.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Equity Capital 14.0013.0013.0013.0012.0012.0012.0012.00
Reserves 262.00200.00194.00181.00134.00121.00109.0075.00
Borrowings 48.0034.0031.0026.0026.0019.0011.0012.00
Other Liabilities 49.0050.0056.0059.0053.0042.0049.0038.00
Total Liabilities 372.00297.00295.00279.00226.00194.00181.00137.00
Fixed Assets 85.0087.0092.0093.0092.0090.0034.0024.00
CWIP 0.000.000.000.000.000.0040.0015.00
Investments 0.000.000.000.000.000.000.000.00
Other Assets 287.00210.00203.00186.00133.00104.00107.0097.00
Total Assets 372.00297.00295.00279.00226.00194.00181.00137.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Cash from Operating Activity -33.00-8.00-7.00-6.004.0013.0013.004.00
Cash from Investing Activity -3.00-1.00-6.00-6.00-8.00-18.00-37.00-15.00
Cash from Financing Activity 64.00-1.006.0029.004.006.0019.00-4.00
Net Cash Flow 28.00-11.00-6.0017.000.001.00-5.00-14.00
Free Cash Flow -38.00-10.00-13.00-13.00-4.00-5.00-25.00-11.00
CFO/OP % -159.00-47.00-16.00-13.0030.0088.0088.0048.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debtor Days 151.00155.00112.00169.00200.00170.00145.00129.00
Inventory Days 251.00268.00234.00228.00188.0027.0078.0067.00
Days Payable 144.00184.00154.00241.00302.00169.00173.00134.00
Cash Conversion Cycle 259.00239.00193.00156.0086.0028.0051.0062.00
Working Capital Days 193.00186.00123.00156.00147.00126.00130.00116.00
ROCE % 5.006.008.0010.0012.0013.0016.00โ€”

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 40.46 40.46 40.46 40.46 40.46 43.16 42.99 42.99 42.99 43.21 43.21 43.21
FIIs 0.07 0.10 0.02 0.05 0.00 0.12 0.06 0.06 0.06 0.12 0.22 0.22
DIIs 0.40 0.00 0.44 0.59 0.64 0.69 0.87 1.17 1.17 0.99 0.67 0.20
Public 59.01 59.39 59.02 58.84 58.83 55.99 56.04 55.79 55.78 55.69 55.90 56.38
No. of Shareholders 11,047 10,806 10,967 11,177 10,808 10,435 10,576 10,792 10,652 10,639 10,252 9,419

Corporate Actions

10 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Dividend 19 Sep 2025 19 Sep 2025 โ€” 1.00
Dividend 19 Sep 2024 โ€” โ€” 1.00
Dividend 20 Sep 2023 โ€” โ€” 1.00
Dividend 19 Sep 2022 โ€” โ€” 1.00
Dividend 16 Sep 2021 โ€” โ€” 1.00
Dividend 17 Sep 2020 โ€” โ€” 0.50
Dividend 17 Sep 2019 18 Sep 2019 โ€” 1.00
Dividend 08 Aug 2017 09 Aug 2017 โ€” 1.00
Dividend 21 Sep 2010 โ€” โ€” 0.75
Other 18 Mar 2002 31 Mar 2002 โ€” โ€” Voluntary Delisting of Shares

Announcements

5 filings